Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
For a dedicated regulatory tracker, see our Retatrutide approval status 2026 article
This medication passes into breast milk
Hepatic Lipid Metabolism Researchers studying NAFLD and MASH models have examined retatrutide's effect on hepatic triglyceride content, where glucagon-receptor agonism is hypothesized to drive intrahepatic lipid mobilization beyond what GLP-1 alone produces
Sources Eli Lilly press release: Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
US$ 23.94
US$ 26.04
US$ 24.25
US$ 29.60
US$ 27.80
US$ 28.56
US$ 24.28
US$ 24.64
US$ 29.46
US$ 23.42
